LabCorp

PharmaShots Weekly Snapshots (May 03 – 07, 2021)

AstraZeneca Reports Results of Imfinzi (durvalumab) and Imfinzi + Tremelimumab in P-III POSEIDON Study as 1L Treatment for Stage IV Non-Small Cell Lung Cancer Published: May 7, 2021 | Tags: AstraZeneca, Imfinzi, durvalumab, Tremelimumab, P-III, POSEIDON Study, Stage IV Non-Small Cell Lung Cancer Merck and Fusion Pharmaceuticals Enter into a Clinical Collaboration for FPI-1434 + …

PharmaShots Weekly Snapshots (May 03 – 07, 2021) Read More »

Labcorp to Acquire Myriad’s Vectra Testing Business for $150M

Shots: Labcorb acquires the Vectra RA test from Myriad Genetics along with other operating assets and IP for $150M in cash. The transaction is expected to close in Q3’21 The divestiture of Myriad auto immune’s Vectra testing business allow Labcorb to bolster its rheumatology and autoimmune portfolios Vectra is a non-invasive, blood-based test that analyzes …

Labcorp to Acquire Myriad’s Vectra Testing Business for $150M Read More »

Labcorp to Acquire Myriad’s Vectra Testing Business for $150M

Shots: Labcorb acquires the Vectra RA test from Myriad Genetics along with other operating assets and IP for $150M in cash. The transaction is expected to close in Q3’21 The divestiture of Myriad auto immune’s Vectra testing business allow Labcorb to bolster its rheumatology and autoimmune portfolios Vectra is a non-invasive, blood-based test that analyzes …

Labcorp to Acquire Myriad’s Vectra Testing Business for $150M Read More »

CommonHealth App Connects to 230 Health Systems to Share Health Data – including COVID Test and Vaccine Status

What You Should Know: – CommonHealth has connected to 230 health systems in the United States, allowing patients to gather, manage and share their health and test data, including COVID test and vaccination status. By the end of this month, CommonHealth will connect to more than 340 health systems – CommonHealth extends the health data …

CommonHealth App Connects to 230 Health Systems to Share Health Data – including COVID Test and Vaccine Status Read More »

Ciox Health Acquires Biomedical NLP Company Medal

What You Should Know: – Ciox Health has acquired Medal, Inc., a biomedical Natural Language Processing (biomed-NLP) technology company. – The acquisition will lead Ciox to better and more quickly enable real-world data in support of research that advances patient care. Ciox Health, a leading health technology company, today announced its acquisition of San Francisco-based biomedical Natural Language …

Ciox Health Acquires Biomedical NLP Company Medal Read More »